Perform Another (Advanced) Search

1. Advanced/Specific Search Results Invirase [saquinavir]
...Advanced/Specific Search Results Invirase [saquinavir] Clinical Trial Results: Invirase [saquinavir] Product Name: Invirase [saquinavir] Date of Report: To be Published Phase: IV ESPrES 500 Study ...
View Page

2.  Newly Approved Drug Therapies (8) Invirase (saquinavir), Roche,
...Newly Approved Drug Therapies (8) Invirase (saquinavir), Roche, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Invirase (saquinavir) Company: Roche Approval Status: Approved on December 7, 1995 Treatment Area: HIV/AIDS General Information ...
View Page

3.  Study Posting (4519) Trial #109724, HIV Infections, Philadelphia, PA
...Study Posting (4519) Trial #109724, HIV Infections, Philadelphia, PA Trial Information A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection. Status: No longer recruiting Protocol Number: BP17921 ...
...Company Division: Pharmaceutical Official Scientific Title: Effect of moderate liver impairment on the pharmacokinetics of saquinavir after administration of saquinavir/ritonavir 1000/100mg BID in HIV patients Brief Summary: This 2 ...
View Page

4.  Study Posting (4519) Trial #116250, HIV Infections, Toronto, ON, Canada
...Study Posting (4519) Trial #116250, HIV Infections, Toronto, ON, Canada Trial Information A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection. Status: No longer recruiting Protocol Number: BP17921 ...
...Company Division: Pharmaceutical Official Scientific Title: Effect of moderate liver impairment on the pharmacokinetics of saquinavir after administration of saquinavir/ritonavir 1000/100mg BID in HIV patients Brief Summary: This 2 ...
View Page

5.  Study Posting (4519) Trial #109709, HIV Infections, Ottawa, ON, Canada
...Study Posting (4519) Trial #109709, HIV Infections, Ottawa, ON, Canada Trial Information A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection. Status: No longer recruiting Protocol Number: BP17921 ...
...Company Division: Pharmaceutical Official Scientific Title: Effect of moderate liver impairment on the pharmacokinetics of saquinavir after administration of saquinavir/ritonavir 1000/100mg BID in HIV patients Brief Summary: This 2 ...
View Page

6.  Study Posting (4519) Trial #109723, HIV Infections, Somers Point, NJ
...Study Posting (4519) Trial #109723, HIV Infections, Somers Point, NJ Trial Information A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection. Status: No longer recruiting Protocol Number: BP17921 ...
...Company Division: Pharmaceutical Official Scientific Title: Effect of moderate liver impairment on the pharmacokinetics of saquinavir after administration of saquinavir/ritonavir 1000/100mg BID in HIV patients Brief Summary: This 2 ...
View Page

7.  Study Posting (4519) Trial #109781, HIV Infections, Santurce, Puerto Rico, Puerto Rico
...4519) Trial #109781, HIV Infections, Santurce, Puerto Rico, Puerto Rico Trial Information A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection. Status: No longer recruiting Protocol Number: BP17921 ...
...Company Division: Pharmaceutical Official Scientific Title: Effect of moderate liver impairment on the pharmacokinetics of saquinavir after administration of saquinavir/ritonavir 1000/100mg BID in HIV patients Brief Summary: This 2 ...
View Page

8. Clinical Trial Results by Drug Names
...Study: A 48-week, randomized, open-label, 2-arm study to compare the efficacy of saquinavir/ritonavir BID plus emtricitabine/tenofovir QD versus lopinavir/ritonavir BID plus emtricitabine/tenofovir QD in ...
...Protocol number: ML18413 Sponsor: Roche Laboratories Inc Company division: Pharmaceutical Product name: Invirase Generic name: saquinavir Phase of development: IV Therapeutic area, approved indication: HIV infections Date of report: 1/9 ...
View Page

9.  Study Posting (4519) Trial #100156, HIV Infections, Bangkok, Thailand
...Posting (4519) Trial #100156, HIV Infections, Bangkok, Thailand Trial Information GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection Status: Completed Protocol Number: ML18413 Sponsor ...
...Title: A 48-week, randomized, open-label, 2-arm study to compare the efficacy of saquinavir/ritonavir BID plus emtricitabine/tenofovir QD versus lopinavir/ritonavir BID plus emtricitabine/tenofovir QD in ...
View Page

10.  Study Posting (4519) Trial #104485, HIV Infections, Tourcoing, France
...Posting (4519) Trial #104485, HIV Infections, Tourcoing, France Trial Information GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection Status: Completed Protocol Number: ML18413 Sponsor ...
...Title: A 48-week, randomized, open-label, 2-arm study to compare the efficacy of saquinavir/ritonavir BID plus emtricitabine/tenofovir QD versus lopinavir/ritonavir BID plus emtricitabine/tenofovir QD in ...
View Page

11.  Study Posting (4519) Trial #97486, HIV Infections, Strasbourg, France
...Posting (4519) Trial #97486, HIV Infections, Strasbourg, France Trial Information GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection Status: Completed Protocol Number: ML18413 Sponsor ...
...Title: A 48-week, randomized, open-label, 2-arm study to compare the efficacy of saquinavir/ritonavir BID plus emtricitabine/tenofovir QD versus lopinavir/ritonavir BID plus emtricitabine/tenofovir QD in ...
View Page

12.  Study Posting (4519) Trial #97407, HIV Infections, Paris, France
...Posting (4519) Trial #97407, HIV Infections, Paris, France Trial Information GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection Status: Completed Protocol Number: ML18413 Sponsor ...
...Title: A 48-week, randomized, open-label, 2-arm study to compare the efficacy of saquinavir/ritonavir BID plus emtricitabine/tenofovir QD versus lopinavir/ritonavir BID plus emtricitabine/tenofovir QD in ...
View Page

13.  Study Posting (4519) Trial #97402, HIV Infections, Nice, France
...Posting (4519) Trial #97402, HIV Infections, Nice, France Trial Information GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection Status: Completed Protocol Number: ML18413 Sponsor ...
...Title: A 48-week, randomized, open-label, 2-arm study to compare the efficacy of saquinavir/ritonavir BID plus emtricitabine/tenofovir QD versus lopinavir/ritonavir BID plus emtricitabine/tenofovir QD in ...
View Page

14.  Study Posting (4519) Trial #98164, HIV Infections, Nantes, France
...Posting (4519) Trial #98164, HIV Infections, Nantes, France Trial Information GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection Status: Completed Protocol Number: ML18413 Sponsor ...
...Title: A 48-week, randomized, open-label, 2-arm study to compare the efficacy of saquinavir/ritonavir BID plus emtricitabine/tenofovir QD versus lopinavir/ritonavir BID plus emtricitabine/tenofovir QD in ...
View Page

15.  Study Posting (4519) Trial #97358, HIV Infections, Marseille, France
...Posting (4519) Trial #97358, HIV Infections, Marseille, France Trial Information GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection Status: Completed Protocol Number: ML18413 Sponsor ...
...Title: A 48-week, randomized, open-label, 2-arm study to compare the efficacy of saquinavir/ritonavir BID plus emtricitabine/tenofovir QD versus lopinavir/ritonavir BID plus emtricitabine/tenofovir QD in ...
View Page

16.  Study Posting (4519) Trial #96605, HIV Infections, Lyon, France
...Posting (4519) Trial #96605, HIV Infections, Lyon, France Trial Information GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection Status: Completed Protocol Number: ML18413 Sponsor ...
...Title: A 48-week, randomized, open-label, 2-arm study to compare the efficacy of saquinavir/ritonavir BID plus emtricitabine/tenofovir QD versus lopinavir/ritonavir BID plus emtricitabine/tenofovir QD in ...
View Page

17.  Study Posting (4519) Trial #96514, HIV Infections, Toronto, ON, Canada
...4519) Trial #96514, HIV Infections, Toronto, ON, Canada Trial Information GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection Status: Completed Protocol Number: ML18413 Sponsor ...
...Title: A 48-week, randomized, open-label, 2-arm study to compare the efficacy of saquinavir/ritonavir BID plus emtricitabine/tenofovir QD versus lopinavir/ritonavir BID plus emtricitabine/tenofovir QD in ...
View Page

18.  Study Posting (4519) Trial #98839, HIV Infections, Ottawa, ON, Canada
...4519) Trial #98839, HIV Infections, Ottawa, ON, Canada Trial Information GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection Status: Completed Protocol Number: ML18413 Sponsor ...
...Title: A 48-week, randomized, open-label, 2-arm study to compare the efficacy of saquinavir/ritonavir BID plus emtricitabine/tenofovir QD versus lopinavir/ritonavir BID plus emtricitabine/tenofovir QD in ...
View Page

19.  Study Posting (4519) Trial #96415, HIV Infections, Montreal, QC, Canada
...4519) Trial #96415, HIV Infections, Montreal, QC, Canada Trial Information GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection Status: Completed Protocol Number: ML18413 Sponsor ...
...Title: A 48-week, randomized, open-label, 2-arm study to compare the efficacy of saquinavir/ritonavir BID plus emtricitabine/tenofovir QD versus lopinavir/ritonavir BID plus emtricitabine/tenofovir QD in ...
View Page

20.  Study Posting (4519) Trial #98777, HIV Infections, Hamilton, ON, Canada
...4519) Trial #98777, HIV Infections, Hamilton, ON, Canada Trial Information GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection Status: Completed Protocol Number: ML18413 Sponsor ...
...Title: A 48-week, randomized, open-label, 2-arm study to compare the efficacy of saquinavir/ritonavir BID plus emtricitabine/tenofovir QD versus lopinavir/ritonavir BID plus emtricitabine/tenofovir QD in ...
View Page